Scrutiny Of EpiPen Pricing Invited By Mylan Lobbying, Congressman Says

House Oversight Committee’s diatribe against Mylan has been fueled by the company’s efforts to engage lawmakers to advance its business interests, Rep. Mulvaney tells CEO Bresch: 'You asked for it.'